Companies / Editas Medicine, Inc.

Editas Medicine, Inc.

Nasdaq: EDITCIK 1650664CAMBRIDGE, MAeditasmedicine.com ↗

Financials · FY2025

Revenue$40.52M
Net income$-160.06M
Total debt$48.24M
Cash$181.81M
Diluted EPS$-1.80
Shares outstanding153.6M

Ownership

153.6M shares outstanding · as of Jul 31, 2026
0.23%Insiders
Ownership
Insiders0.23%347,155
Institutions35.51%54,531,551
Public float64.27%98,701,329

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
O'Neill Gilmore NeilCEOCEO · Director
0.17%263,693
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
0.04%68,028
Parison AmySVP, Chief Financial Officer
0.01%15,434
Ellinor Patrick Thomas IIDirector
——

Institutional holders 202

View all →
HolderValue% of shares
BlackRock, Inc.$34.31M6.90%
Vanguard Group Inc$16.83M5.34%
Renaissance Technologies LLC$9.81M2.59%
State Street Corporation$7.10M1.43%
Geode Capital Management, LLC$5.71M1.51%
D. E. Shaw & Co., Inc.$4.80M1.27%
Nuveen, LLC$4.05M1.29%
Two Sigma Investments, LP$3.83M1.01%
AQR Capital Management, LLC$3.39M0.89%
Two Sigma Advisers, LP$2.51M0.80%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon stock$4.03M+1.2M
+13.30%
10,589,990
6.90% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
AddCommon stock$2.30M+932K
+30.67%
3,972,160
2.59% of shares
low
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
AddCommon stock$2.06M+834K
+75.19%
1,943,893
1.27% of shares
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
AddCommon stock$1.79M+726K
+112.75%
1,370,497
0.89% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon stock$-1.70M-831K
-81.09%
193,675
0.13% of shares
low
Q1 2023
as of
Barclays PLC
13F manager
TrimCommon stock$-1.20M-165K
-37.53%
275,122
0.18% of shares
low
Q1 2024
as of
Barclays PLC
13F manager
TrimCommon stock$-999.6K-135K
-48.21%
144,723
0.09% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon stock$702.7K+217K
+10.98%
2,191,803
1.43% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
RA Capital Management, L.P.Passive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
EDIT——28106W103—